Mereo BioPharma Group PLC ADR (MREO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.39
• Market Cap: $62.70M
• EPS: $-0.25
• 52-Week High: $3.05
• 52-Week Low: $0.20

Market Sentiment

Mereo BioPharma Group PLC ADR currently has a Bearish sentiment score of -0.63.

About Mereo BioPharma Group PLC ADR

Mereo BioPharma Group PLC is a biopharmaceutical company based in London, dedicated to advancing innovative therapeutics for oncology and rare diseases. With a strategic focus on addressing unmet medical needs, Mereo is developing a diverse pipeline of novel treatments aimed at significantly improving patient outcomes. The company leverages its clinical development expertise and a strong portfolio to position itself effectively within the competitive biopharmaceutical sector, thereby enhancin...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Mereo BioPharma Group PLC ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MREO pay dividends?

Mereo BioPharma Group PLC ADR (MREO) does not currently pay a regular dividend.

What is MREO's market cap?

Mereo BioPharma Group PLC ADR (MREO) has a market capitalization of $62.70M with a current stock price of $0.39.